Dog Vaccines Market Size, Competitors & Forecast to 2032

The Dog Vaccines Market is navigating a pivotal transformation, propelled by scientific innovation, evolving distribution strategies, and changing policy landscapes. Decision-makers need targeted insights to effectively balance innovation, operational resilience, and market entry strategies in a sector defined by complexity and growth potential.

Market Snapshot

The Dog Vaccines Market grew from USD 2.40 billion in 2025 to USD 2.60 billion in 2026 and is forecasted to grow at a CAGR of 8.26%, reaching USD 4.18 billion by 2032. Stakeholders are responding to stronger demand for preventive healthcare, progressive scientific advances in vaccine platforms, and a globalized supply chain with highly variable regulatory and trade dynamics. This environment calls for robust, forward-thinking strategies to achieve sustained commercial success.

Scope & Segmentation

Platform Types: Inactivated, live attenuated, and recombinant vaccine platforms, encompassing DNA, mRNA (including non-replicating and self-amplifying), and vector-based approaches.
Distribution Channels: Animal hospitals, veterinary clinics, pharmacies, and online retail with both traditional and direct-to-consumer models influencing supply pathways and customer interactions.
End-User Groups: Pet owners, research institutes, and veterinary hospitals, each with differing evidence requirements and purchasing priorities.
Age-Based Segmentation: Products tailored for puppies, adult dogs, and seniors, each presenting unique clinical profiles and communication needs.
Geographical Regions: Americas; Europe, Middle East & Africa; Asia-Pacific, each characterized by specific adoption drivers, regulatory diversity, and technological capacity.

Key Takeaways

Biological platform advancements like nucleic acid and vector systems are accelerating vaccine development with greater precision, influencing product lifecycles and investment choices.
Supply chains are becoming more complex, integrating global suppliers, contract manufacturers, and a mix of digital and traditional distribution channels, underscoring the need for resilient procurement strategies.
Distribution evolution—including the rise of direct-to-consumer models and bundled veterinary services—is changing how commercial players engage end users and structure adherence programs.
Regulatory modernization is raising standards for safety surveillance, real-world data generation, and post-market evidence, prompting manufacturers to expand their data management capabilities.
Segmented strategies are vital; product performance expectations vary significantly by platform, channel, end user, and animal age, informing both product design and commercialization efforts.
Regional differentiation requires adaptable market entry and regulatory engagement to account for nuanced approval processes, procurement systems, and infrastructure disparities.

Tariff Impact on Dog Vaccines Market

Recent tariff changes are prompting reevaluation of sourcing and manufacturing strategies. Companies are adapting by:

Geographically diversifying supplier networks to reduce exposure to international trade friction.
Renegotiating long-term agreements and building regional manufacturing capacity to address border measures and transit uncertainties.
Embedding tariff awareness into procurement, pricing, and investment frameworks to enhance operational resilience and safeguard access to critical inputs.

Methodology & Data Sources

This research employs a rigorous mixed-methods approach, combining expert interviews with key stakeholders, systematic analysis of secondary scientific and regulatory literature, supply chain mapping, and multi-source validation. Data integrity was ensured through peer review, source verification, and thorough documentation processes.

Why This Report Matters

Delivers clarity on integrating scientific, operational, and policy developments for executive-level decision-making.
Equips strategists to prioritize investments, craft regional market entries, and de-risk supply chains in a context of increasing complexity.
Provides a structured foundation to drive evidence-based product development, partnership formation, and regulatory engagement.

Conclusion

The dog vaccines sector stands at the intersection of scientific opportunity and operational sophistication. Decision-makers who synthesize platform innovation, segmented needs, and regional demands will position their organizations for enduring value and competitive strength.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Dog Vaccines Market, by Vaccine Type

8.1. Inactivated
8.2. Live Attenuated
8.3. Recombinant

9. Dog Vaccines Market, by Technology

9.1. DNA
9.2. mRNA
9.2.1. Non-Replicating
9.2.2. Self-Amplifying
9.3. Vector

10. Dog Vaccines Market, by Animal Age Group

10.1. Adult
10.2. Puppy
10.3. Senior

11. Dog Vaccines Market, by Distribution Channel

11.1. Animal Hospitals
11.2. Online Retail
11.3. Pharmacies
11.4. Veterinary Clinics

12. Dog Vaccines Market, by End User

12.1. Pet Owners
12.2. Research Institutes
12.3. Veterinary Hospitals

13. Dog Vaccines Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Dog Vaccines Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Dog Vaccines Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Dog Vaccines Market
17. China Dog Vaccines Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Anicon Labor GmbH by SNA group
18.6. Biogénesis Bagó S.A.
18.7. Boehringer Ingelheim International GmbH
18.8. Brilliant Bio Pharma Private limited
18.9. Ceva Santé Animale
18.10. China Animal Husbandry Industry Co., Ltd.
18.11. Elanco LLC
18.12. Endovac Animal Health, LLC
18.13. Heska Corporation
18.14. Hester Biosciences Limited
18.15. HIPRA, S.A.
18.16. Indian Immunologicals Limited
18.17. Merck KGaA
18.18. Neogen Corporation
18.19. Phibro Animal Health Corporation
18.20. Sanofi S.A.
18.21. Torigen Pharmaceuticals Inc.
18.22. Vaxxinova GmbH
18.23. VEROVACCiNES GmbH
18.24. Vetoquinol SA
18.25. Virbac, Inc.
18.26. Zoetis Inc.

List of Figures

FIGURE 1. GLOBAL DOG VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DOG VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DOG VACCINES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DOG VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES DOG VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA DOG VACCINES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL DOG VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DOG VACCINES MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DOG VACCINES MARKET SIZE, BY INACTIVATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DOG VACCINES MARKET SIZE, BY INACTIVATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DOG VACCINES MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DOG VACCINES MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DOG VACCINES MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DOG VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DOG VACCINES MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DOG VACCINES MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DOG VACCINES MARKET SIZE, BY DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DOG VACCINES MARKET SIZE, BY DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DOG VACCINES MARKET SIZE, BY DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DOG VACCINES MARKET SIZE, BY MRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DOG VACCINES MARKET SIZE, BY MRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DOG VACCINES MARKET SIZE, BY MRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DOG VACCINES MARKET SIZE, BY NON-REPLICATING, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DOG VACCINES MARKET SIZE, BY NON-REPLICATING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DOG VACCINES MARKET SIZE, BY NON-REPLICATING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DOG VACCINES MARKET SIZE, BY SELF-AMPLIFYING, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DOG VACCINES MARKET SIZE, BY SELF-AMPLIFYING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DOG VACCINES MARKET SIZE, BY SELF-AMPLIFYING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DOG VACCINES MARKET SIZE, BY VECTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DOG VACCINES MARKET SIZE, BY VECTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DOG VACCINES MARKET SIZE, BY VECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DOG VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DOG VACCINES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DOG VACCINES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DOG VACCINES MARKET SIZE, BY PUPPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DOG VACCINES MARKET SIZE, BY PUPPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DOG VACCINES MARKET SIZE, BY PUPPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DOG VACCINES MARKET SIZE, BY SENIOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DOG VACCINES MARKET SIZE, BY SENIOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DOG VACCINES MARKET SIZE, BY SENIOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DOG VACCINES MARKET SIZE, BY ANIMAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DOG VACCINES MARKET SIZE, BY ANIMAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DOG VACCINES MARKET SIZE, BY ANIMAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DOG VACCINES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DOG VACCINES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DOG VACCINES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DOG VACCINES MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DOG VACCINES MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DOG VACCINES MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DOG VACCINES MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DOG VACCINES MARKET SIZE, BY PET OWNERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DOG VACCINES MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DOG VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DOG VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DOG VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS DOG VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. EUROPE DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. EUROPE DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 94. EUROPE DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 95. EUROPE DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 96. EUROPE DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. EUROPE DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. AFRICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 107. AFRICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 108. AFRICA DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 109. AFRICA DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 110. AFRICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. AFRICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL DOG VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. ASEAN DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASEAN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 122. ASEAN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 123. ASEAN DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 124. ASEAN DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 125. ASEAN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. ASEAN DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. GCC DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GCC DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 129. GCC DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 130. GCC DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 131. GCC DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 132. GCC DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. GCC DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. EUROPEAN UNION DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. BRICS DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. BRICS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 143. BRICS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 144. BRICS DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 145. BRICS DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 146. BRICS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. BRICS DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. G7 DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. G7 DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 150. G7 DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. G7 DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 152. G7 DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 153. G7 DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. G7 DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. NATO DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. NATO DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 157. NATO DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 158. NATO DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 159. NATO DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 160. NATO DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. NATO DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES DOG VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 164. UNITED STATES DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 165. UNITED STATES DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 166. UNITED STATES DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 167. UNITED STATES DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 168. UNITED STATES DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. CHINA DOG VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 171. CHINA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 172. CHINA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 173. CHINA DOG VACCINES MARKET SIZE, BY MRNA, 2018-2032 (USD MILLION)
TABLE 174. CHINA DOG VACCINES MARKET SIZE, BY ANIMAL AGE GROUP, 2018-2032 (USD MILLION)
TABLE 175. CHINA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. CHINA DOG VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Dog Vaccines market report include:

Anicon Labor GmbH by SNA group
Biogénesis Bagó S.A.
Boehringer Ingelheim International GmbH
Brilliant Bio Pharma Private limited
Ceva Santé Animale
China Animal Husbandry Industry Co., Ltd.
Elanco LLC
Endovac Animal Health, LLC
Heska Corporation
Hester Biosciences Limited
HIPRA, S.A.
Indian Immunologicals Limited
Merck KGaA
Neogen Corporation
Phibro Animal Health Corporation
Sanofi S.A.
Torigen Pharmaceuticals Inc.
Vaxxinova GmbH
VEROVACCiNES GmbH
Vetoquinol SA
Virbac, Inc.
Zoetis Inc.

Table Information

Report Attribute	Details
No. of Pages	199
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.6 Billion
Forecasted Market Value ( USD ) by 2032	$ 4.18 Billion
Compound Annual Growth Rate	8.2%
Regions Covered	Global
No. of Companies Mentioned	23

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3400EUR$3,939USD£2,946GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3668EUR$4,249USD£3,178GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4971EUR$5,759USD£4,307GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6016EUR$6,969USD£5,212GBP

Dog Vaccines Market - Global Forecast 2026-2032

Market Snapshot

Scope & Segmentation

Key Takeaways

Tariff Impact on Dog Vaccines Market

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot

Scope & Segmentation

Key Takeaways

Tariff Impact on Dog Vaccines Market

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030

United States Vaccine Market Report and Forecast 2024-2032

North America Vaccines Market Outlook, 2028

Vaccine Management Solutions - Global Strategic Business Report

Companion Animal Vaccine Market - Global Forecast 2026-2032

About the Canine Vaccine Market